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UPDATE ON THE NEW LIFETIME SURVEILLANCE OF ASTRONAUT
HEALTH (LSAH) PROGRAM: COMPREHENSIVE MEDICAL EXAMS
BY: LESLEY LEE, M.S.
The June 2010 LSAH newsletter introduced           the change from the Longitudinal Study of            Astronaut Health research study to the new
Lifetime Surveillance of Astronaut Health program (“An
Overview of the New Occupational Surveillance Pro-
gram for the Astronaut Corps”).  Instead of perform-
ing research-focused retrospective analyses of
astronaut medical data compared to a JSC civil
servant control population, the new program is
focused on prevention of disease and prospective
identification and mitigation of health risks in each
astronaut due to individual exposure history and
the unique occupational exposures experienced by
the astronaut corps.  The new LSAH program has
5 primary goals:  (1) Provide a comprehensive
medical exam for each LSAH participant;
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TRADITIONAL CARDIOVASCULAR RISK FACTORS AS PREDICTORS OF
CARDIOVASCULAR EVENTS IN THE U.S. ASTRONAUT CORPS
BY: MELISSA HALM, MPH and E. AMIRIAN, PhD
The Framingham Risk Score (FRS) assesses the            absolute 10-year risk for myocardial infarction          (MI) and coronary heart disease (CHD)-related
death, using a predictive model developed from data
collected during the Framingham Heart Study. The FRS
calculation is dependent upon traditional CHD risk
factors: age, total and high density lipoprotein (HDL)
cholesterol, systolic blood pressure and treatment, and
smoking status. However, numerous studies have
documented that the FRS under- or overestimates CHD
in populations exhibiting different demographics than
the Framingham Heart Study population (1,2).
NASA currently uses FRS to assess the 10-year risk
for CHD in astronauts. However, the demographics of
the U.S. astronaut corps differ greatly from the
Framingham Heart Study population. Furthermore,
astronauts experience unique exposures during
spaceflight training and participation that could affect
their cardiovascular health. Currently, it is difficult to
determine the accuracy of the FRS in predicting the 10-
year CHD risk in the astronaut corps due to the small
number of CHD events. However, given the unusual
demographic profile and unique exposures of this study
population, NASA medical personnel have determined
the need to develop a predictive model specific to U.S.
astronauts. This analysis provides some evidence that
risk factors traditionally used to predict CHD in the
general population may lack the ability to predict CHD
events in astronauts.  Furthermore, the article discusses
imaging techniques that are being considered for
inclusion in the new predictive model in an effort to add
sensitivity and specificity. This material was presented
at a poster session at the Kelsey-Seybold Foundation’s
10th Annual Health Services and Outcomes Research
Conference, December 2009.
Study Population & Data Collection
All U.S. astronauts (n=321), from the first selection class
of 1959 through the selection class of 2004, were in-
cluded in this analysis. Women were first selected into
the US astronaut corps in 1978. The selection criteria
for acceptance into the astronaut corps has evolved
since 1959, but candidates generally have been
screened for appropriate expertise, education, and over-
all health (3). Payload specialists, international partners,
and other space flight participants were excluded from
these analyses due to lack of outcome data. Death
certificate searches were conducted to ascertain
vital statistics and cause of death through April 2009.
Information on demographic and health character-
istics collected at baseline and last physical were
obtained from medical records and lifestyle ques-
tionnaires (Table 1). The outcome was defined as
hard coronary heart disease events, including CHD-
related deaths or MIs.
Analyses
Low density lipoprotein (LDL) and HDL levels, sys-
tolic and diastolic blood pressure, and resting pulse
were evaluated as predictors of CHD death or MI
using exploratory, multivariable Cox proportional
hazards regression modeling.  The proportional
hazards assumption was checked using log-cumu-
lative hazard plots. Each factor was initially evalu-
ated in a univariable model.  A backward stepwise
model building strategy was utilized to identify sig-
nificant predictors of CHD hazard over time (α=0.10)
(Table 2).
Of all the traditional CHD risk factors examined in
this study, only low-density lipoprotein level at
baseline is a significant predictor of CHD death or
Table 1. Frequency distributions of selected
characteristics of astronauts
Variable
Overall
(n=321)
No. (%)
Age at selection
<35 years 176 (54.8)
≥35 years 145 (45.2)
Sex
Male 276 (86.0)
Female 45 (14.0)
Race
Non-Hispanic white 293 (91.3)
Other 28 (8.7)
Marital Status
Married 262 (81.6)
Unmarried 59 (18.4)
Educational Level
Bachelors 54 (16.8)
Masters 161 (50.2)
Doctoral 106 (33.0)
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MI in the U.S. astronaut corps. It appears that for every
5mg/dl increase in LDL, there is an approximate 10%
increase in CHD death or MI risk over time (Hazard
Ratio: 1.10; 95% CI: 1.02-1.18). Refer to Table 2. While
these results may be due in part to inadequate statisti-
cal power, it is also plausible that the astronaut corps is
so different from the general population that more sen-
sitive, non-traditional measures are needed to assess
CHD risk appropriately, consequently directing clinical
practice guidelines.
Further collection of data on CHD risk factors and out-
comes in the astronaut corps is vital both for the devel-
opment of a new predictive model to assess CHD risk
and for increasing the statistical power of existing risk
assessments. Moreover, including imaging measures
as part of the astronauts’ standard clinical care regi-
men will provide more comprehensive information for
use in the development of new CHD risk assessment
strategies.
Developing a very sensitive and specific predictive
model using traditional and non-traditional risk factors
to assess astronaut CHD risk is a high priority for space
medicine. This new  model will be developed specifi-
cally for use in the U.S. astronaut corps and can thus
maximize predictive accuracy in this unique population,
potentially incorporating occupational exposures and
other specific factors that may not necessarily be rel-
evant to the general public. The importance of such a
model would be that it could help determine the health-
iest astronauts for participation in long duration mis-
sions (such as missions to Mars) and thus, could help
prevent CHD events from occurring in space during
such missions.
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Table 2. Cox proportional hazards regression analysis results showing
           univariable (A) and multivariable (B) results
Note. Further adjustment for race, education, and sex has no effect on the Hazard Ratios presented; race,
education, and sex are not predictive of CHD over time in our study population.
*Characteristic measured at baseline unless otherwise indicated.
Cardiovascular Risk Factors, continued from previous page
Characteristic* Hazard Ratio
(95% CI)
(n=321)
Panel A
Low-density lipoprotein (per 5mg/dl increase) 1.10 (1.02-1.18)
High-density lipoprotein (per 5mg/dl increase) 0.80 (0.60-1.06)
Resting pulse (per 5 beat increase) 1.19 (0.81-1.75)
Systolic blood pressure (mmHg) 1.05 (0.98-1.14)
Diastolic blood pressure(mmHg) 1.06 (0.95-1.18)
Panel B
Low-density lipoprotein (per 5mg/dl increase) 1.11 (1.03-1.20)
Resting pulse (per 5 beat increase) 1.29 (0.88-1.91)
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(2) Conduct occupational surveillance; (3) Im-
prove communication, data accessibility, integ-
rity and storage; (4) Support operational and
healthcare analyses; and (5) Support NASA
research objectives.  This article will focus
primarily on the first goal, the comprehensive
medical exam.  Future newsletters will outline in
detail the plans and processes for  addressing
the remaining program goals.
During the past year, recommendations from the
Institute of Medicine and other experts in the field
of occupational surveillance have been incorpo-
rated into planning the new LSAH.  The program
is designed to fit the medical follow-up care to
the individual since not all astronauts have been
equally exposed to hazards before, during, or
following their NASA career.  The new LSAH is
also designed to enhance communications with
astronauts and their primary care physicians
(PCP).  The purpose is to facilitate continuity of
medical care and follow-up between JSC and
personal clinicians.  The diagram (see page 1)
illustrates the main elements of the annual exam
process.
Primary medical evaluation of the individual will
include a comprehensive medical history, com-
plete physical examination, medical laboratory
tests, and ancillary diagnostic medical tests. This
will be supplemented with individually focused
exams based upon each person’s status and
experiences.  For example, Medical Require-
ment tests may be included for those currently
assigned to a mission, and age-based tests may
be added at certain milestone ages (e.g.
colonoscopy at age 50).  Other tests may be
added for those who have had previous occu-
pational exposures to hazards such as cadmium
or hydrazine.  Additional tests may also be
recommended if the occupational surveillance
element of LSAH provides new evidence
indicating that further screening is warranted.
This comprehensive set of exams will be tailored
to each individual and coordinated to be as
convenient as possible for participants.  Testing
will be conducted at JSC and at local facilities
that offer a wide spectrum of medical screen-
ing/testing capabilities. This will minimize
astronaut travel and wait times.  In the event an
astronaut cannot travel to Houston, arrangements
will be made with the primary care provider for per-
formance of the tests in or near the astronaut’s home
town.
Following the exams, LSAH and the Flight
Medicine Clinic physician will provide a thorough
summary and analysis of results to astronaut and
their PCPs.  Recommendations for follow-up care
in the intervening year may also be discussed.  The
astronaut’s exam results will be documented in the
FMC electronic medical record system.  Surveillance
is the ongoing systematic collection, analysis, and
interpretation of health data for purposes of improv-
ing health and safety.  Data gathered in this
process are used to improve astronaut safety and
health and to monitor health trends over time.  LSAH
surveillance will involve the timely dissemination of
these data to those who need to know, including
publication of non-attributable data, and proactive
application of these data to the astronaut clinical
care setting. Astronauts and their PCPs will be
among the first to receive notice of any publications
resulting from the occupational surveillance
program.
LSAH will also monitor the United States Preven-
tive Services Task Force (USPSTF) for updates to
national guidelines regarding preventive medicine
exams. New guidelines and recommendations will
be incorporated into the preventive medicine exams
if determined to be appropriate to the astronaut
population.  The new LSAH provides the opportu-
nity for astronauts and their PCPs to be more ac-
tively involved in the clinical care process. The more
comprehensive annual exams, occupational
surveillance, and active participation of astronauts
benefits individual astronauts. It also provides NASA
with a more complete understanding of the
relationships among spaceflight-associated health
hazards and medical outcomes.  The information
to be gained is essential for planning, implementa-
tion, and evaluation of aerospace medicine
practices for the ultimate safety of current and
future astronauts.
Comprehensive Medical Exams, continued from page 1
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Risk of Atrial Arrythmias in the Astronaut Corps
BY: SARA MASON
In January 2010, the JSC Space Medicine     Advanced Projects Section hosted an Atrial     Arrhythmia Summit (1), bringing together medi-
cal experts from the fields of cardiology and elec-
trophysiology to review atrial arrhythmia    incidence
in the astronaut corps. Unique factors which may
contribute to atrial arrhythmias in the astronaut
corps were identified. Recommendations for
screening and treatment were discussed along with
implications for spaceflight.
Since the start of the American manned space flight
program, 17 cases of atrial arrhythmias have been
identified. This equates to 5% prevalence in the
astronaut corps, both active and retired, which is
consistent with the prevalence of atrial arrhythmia
in the general U.S. population. While the risk of
developing atrial arrhythmias is not generally
increased in the overall astronaut corps, when
stratified by age the prevalence among younger
members (early to mid-40s) of the astronaut corps
was notable and greater than would be predicted
based on the general U.S. population. This increase
in prevalence may be due in large part to increased
screening. Most cases were diagnosed during
routine testing, and not related to any report of
symptoms (1).
Factors which may contribute to atrial arrhythmias
include gender, high vagal tone, hypertension, and
alcohol consumption. Prevalence of atrial
arrhythmias in the general population is higher in
males, and since the astronaut corps is  predomi-
nantly male (86%) this could contribute to the
observed prevalence. Another factor which may
contribute is high vagal tone (1). Vagal tone refers
to vagal (vagus nerve) control over resting heart
rate, resulting in lowered heart rate. High vagal tone
is characteristic of high endurance athletes, and the
association between vigorous exercise and the
early development of atrial fibrillation has been well
established (2, 3, 4, 5). In one meta-analysis,
intense aerobic exercise greater than 3.3 hours per
week increased the risk of developing atrial arrhyth-
mia. However, exercise in terms of long term over-
all cardiovascular health are protective (1, 2, 3, 4,
5).
Undiagnosed hypertension is associated with 25%
of lone atrial arrhythmias, i.e. no identifiable
underlying condition, in the general U.S.
population. Following a diagnosis of atrial arrhyth-
mia, careful monitoring of blood pressure was
recommended by the Atrial  Arrythmia Summit panel
to ensure an underlying condition was not over-
looked.  Excessive alcohol consumption has also
been associated with atrial fibrillation.   However,
there is no evidence of a relationship of alcohol
consumption with the atrial arrythmia cases seen
to date in the astronaut corps.
Space flight itself poses a minimal risk to develop-
ing atrial arrhythmias. Fluid shifts could cause atrial
distension, but the panel members thought the in-
flight changes are not significant enough to be
considered a serious risk. Activation of sympathetic
nervous system during stressful events poses
another risk.
Minor arrhythmias during flight are not uncommon
(6). As on the ground, arrhythmias are observed
during testing and the crewmembers are typically
asymptomatic. If  asymptomatic arrhythmias were
to occur, such arrhythmias could be  treated in-flight,
although a crewmember who was hypo-tensive or
in heart failure would have to return to earth for
treatment.
Ablation is the standard treatment for atrial
arrhythmias and is considered a cure in the
majority of cases. Current JSC Space Medicine
clinical guidelines require a 6 month postponement
of training after ablation. At 12 months post-
ablation, an astronaut is again eligible for space
flight  participation (1).
While a current diagnosis for atrial fibrillation is
cause for disqualification during selection,
screening and treatment of atrial arrythmias that
develop  later in an astronaut’s career are  a
priority. The panel of experts from the Atrial Arryth-
mia   Summit agree any history of atrial fibrillation
or  flutter should be cause for disqualification  dur-
ing  selection, since a history of atrial arrhythmias
increases the risk of developing   future arrhythmias
(1).  The panel also concurred with the existing JSC
continued on page 6
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Atrial Arrhythmias, continued from page 5
Space Medicine guidelines for active astronauts and
emphasized rigorous monitoring during recovery and
training.
Other recommendations from the panel included
enhancing current screening protocols of the active
corps. Literature suggests certain parameters should
be measured to assess risk, like increased left atrial
diameter and certain ECG conduction delays, which
may be more  indicative of the risk of developing atrial
arrhythmias in the astronaut corps (1, 2, 3). Changes
to the treadmill protocol, more rigorous monitoring of
hypertension, and an increase in the duration and
sensitivity of Holter monitoring were also among the
suggestions resulting from the summit (1).
The Atrial Arrhythmia summit and summary report
provided valuable information regarding the risk of
atrial arrhythmias in the astronaut population and the
identification and treatment of new cases.  This
review will assist in shaping clinical care guidelines
to ensure the safety and health of all astronauts
during training, space flight, and beyond.
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